Cubist Pharmaceuticals Cash from Investing Quarterly:
-29.37M for March 31, 2013Cubist Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -29.37M |
| Dec. 31, 2012 | -25.69M |
| Sept. 30, 2012 | -141.15M |
| June 30, 2012 | -31.70M |
| March 31, 2012 | -33.89M |
| Dec. 31, 2011 | -129.48M |
| Sept. 30, 2011 | -176.94M |
| June 30, 2011 | -71.86M |
| March 31, 2011 | -61.26M |
| Dec. 31, 2010 | -112.20M |
| Sept. 30, 2010 | -31.09M |
| June 30, 2010 | -53.03M |
| March 31, 2010 | -26.38M |
| Dec. 31, 2009 | -333.16M |
| Sept. 30, 2009 | -24.79M |
| June 30, 2009 | -53.81M |
| March 31, 2009 | -4.458M |
| Dec. 31, 2008 | -5.601M |
| Sept. 30, 2008 | -4.988M |
| June 30, 2008 | -10.01M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
CBST Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Optimer Pharmaceuticals | 65.82M |
| Celgene Corporation | -251.50M |
| Athersys | -0.04M |
CBST Cash from Investing Quarterly Rankings
| Overall |
58th percentile 3302 of 8002 |
| Sector |
32nd percentile 463 of 684 in Healthcare |
| Industry |
26th percentile 182 of 248 in Biotechnology |
CBST Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -333.16M | Dec 2009 |
| Maximum | -4.458M | Mar 2009 |
| Average | -68.04M |
